Most lately, it's been determined that conolidine and the above mentioned derivatives act within the atypical chemokine receptor three (ACKR3. Expressed in very similar regions as classical opioid receptors, it binds to a wide array of endogenous opioids. Not like most opioid receptors, this receptor functions like a scavenger https://buckminsterv629yei2.wikicorrespondence.com/user